Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English...

Area of Science:

• Dermatology
• Clinical Practice Guidelines

Background:

• Alopecia areata (AA) is a complex autoimmune condition affecting hair follicles.
• Existing guidelines require updates to reflect recent scientific advancements and therapeutic options.

Purpose of the Study:

• To present the updated 2024 clinical practice guidelines for alopecia areata (AA) from the Japanese Dermatological Association.
• To provide evidence-based recommendations for the management of AA, incorporating recent research and therapeutic innovations.

Main Methods:

• The guidelines were updated based on the latest evidence and advances in AA research.
• Recommendations were formulated for 25 clinical questions (CQs) with defined evidence and recommendation levels.
• A novel "AA-cube" concept was introduced for personalized treatment strategy visualization.

Main Results:

• The guidelines cover summary, pathogenesis, epidemiology, evaluation, diagnosis, and treatment of AA.
• Specific recommendations address the use of newly approved JAK inhibitors and JAK3/TEC family kinase selective inhibitors.
• The AA-cube provides a framework for tailoring treatment based on individual patient factors.

Conclusions:

• These updated guidelines support evidence-based management of alopecia areata.
• They aim to enhance the understanding of AA's etiopathogenesis and improve patient care through structured treatment approaches.